These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6411131)

  • 21. Prostaglandin H synthase and lipoxygenase mediated activation of xenobiotics in platelets.
    Lim KM; Lee JY; Kim JS; Chung JH
    Adv Exp Med Biol; 1999; 469():631-7. PubMed ID: 10667392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arachidonate metabolism via lipoxygenase and 12L-hydroperoxy-5,8,10,14-icosatetraenoic acid peroxidase sensitive to anti-inflammatory drugs.
    Siegel MI; McConnell RT; Porter NA; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):308-12. PubMed ID: 6767237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition.
    Dejana E; Cerletti C; de Castellarnau C; Livio M; Galletti F; Latini R; de Gaetano G
    J Clin Invest; 1981 Oct; 68(4):1108-12. PubMed ID: 6793630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of action: aspirin.
    Hoak JC
    Thromb Res Suppl; 1983; 4():47-51. PubMed ID: 6415858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simple method for estimation of lipoxygenase and cyclo-oxygenase pathways in human platelets--the use of thiobarbituric acid reaction.
    Takayama H; Okuma M; Uchino H
    Thromb Haemost; 1980 Dec; 44(3):111-4. PubMed ID: 6781093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The inhibition of cyclo-oxygenase of rabbit platelets by aspirin is prevented by salicylic acid and by phenanthrolines.
    Vargaftig BB
    Eur J Pharmacol; 1978 Aug; 50(3):231-41. PubMed ID: 99321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arachidonic acid-induced human platelet aggregation independent of cyclooxygenase and lipoxygenase.
    Maclouf J; Levy-Toledano S; Savariau E; Hardisty R; Caen JP
    Prostaglandins; 1984 Sep; 28(3):383-98. PubMed ID: 6440214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salicylates and 12-lipoxygenase activity in human washed platelets.
    Radomski M; Michalska Z; Marcinkiewicz E; Gryglewski RJ
    Pharmacol Res Commun; 1986 Nov; 18(11):1015-30. PubMed ID: 3797446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential utilization of endogenous arachidonate by cyclo-oxygenase in incubations of human platelets.
    Sautebin L; Caruso D; Galli G; Paoletti R
    FEBS Lett; 1983 Jun; 157(1):173-8. PubMed ID: 6407867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control mechanisms of histamine release from human basophils in vitro: the role of phospholipase A2 and of lipoxygenase metabolites.
    Marone G; Kagey-Sobotka A; Lichtenstein LM
    Int Arch Allergy Appl Immunol; 1981; 66 Suppl 1():144-8. PubMed ID: 6171522
    [No Abstract]   [Full Text] [Related]  

  • 31. Salicylamide reverses the aspirin-antagonistic effect of salicylic acid on rat platelet cyclooxygenase.
    Rizk M; Abdel-Rahman MS
    Prostaglandins Leukot Essent Fatty Acids; 1994 Nov; 51(5):363-7. PubMed ID: 7846108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity.
    Livio M; Del Maschio A; Cerletti C; de Gaetano G
    Prostaglandins; 1982 Jun; 23(6):787-96. PubMed ID: 6812166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of 4,7,10,13,16-docosapentaenoic acid by human platelet cyclooxygenase and lipoxygenase.
    Milks MM; Sprecher H
    Biochim Biophys Acta; 1985 Jun; 835(1):29-35. PubMed ID: 3924108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of 5,8,11,14-eicosatetraynoic acid on lipid metabolism.
    Tobias LD; Hamilton JG
    Lipids; 1979 Feb; 14(2):181-93. PubMed ID: 106197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial cells produce a lipoxygenase derived chemo-repellent which influences platelet/endothelial cell interactions--effect of aspirin and salicylate.
    Buchanan MR; Butt RW; Magas Z; van Ryn J; Hirsh J; Nazir DJ
    Thromb Haemost; 1985 Jun; 53(3):306-11. PubMed ID: 3931280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective inhibition of platelet lipoxygenase by esculetin.
    Sekiya K; Okuda H; Arichi S
    Biochim Biophys Acta; 1982 Oct; 713(1):68-72. PubMed ID: 6814494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation.
    Calzada C; Vericel E; Lagarde M
    Biochem J; 1997 Jul; 325 ( Pt 2)(Pt 2):495-500. PubMed ID: 9230133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salicylic acid fails to inhibit generation of thromboxane A2 activity in platelets after in vivo administration to the rat.
    Vargaftig BB
    J Pharm Pharmacol; 1978 Feb; 30(2):101-4. PubMed ID: 24092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simple single-step high-performance liquid chromatographic method for the separation of cyclooxygenase and lipoxygenase enzyme metabolites of arachidonic acid.
    Cockrell CS; Ellis EF
    J Chromatogr; 1984 Jun; 308():316-21. PubMed ID: 6430943
    [No Abstract]   [Full Text] [Related]  

  • 40. Rapid return of cyclo-oxygenase active platelets in dogs after a single oral dose of aspirin.
    Rao GH; Johnson GJ; Reddy RK; White JG
    Prostaglandins; 1981 Nov; 22(5):761-72. PubMed ID: 6799989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.